You should be re-directed to the full story momentarily. If not, please visit https://physician-news.umiamihealth.org/miller-school-researchers-enter-phase-3-of-stem-cell-clinical-trial-in-treating-covid-19-acute-respiratory-distress-syndrome/.
Introduction Kicker
Miller School Researchers Enter Phase 3 of Stem Cell Clinical Trial in Treating COVID-19 Acute Respiratory Distress Syndrome
A University of Miami Miller School of Medicine research team has launched a Phase 3 multicenter clinical trial to evaluate the effectiveness of mesenchymal stem cells in treating COVID-19 patients with acute respiratory distress syndrome.
